Financial resultsNotable· Adverse for the businessFiled on BSE ·

Mangalam Seeds approves Q2 results, divests subsidiary and associate stakes

Mangalam Seeds · Agricultural Food & other Products

Arthneeti Research DeskPublished 1 min read
90%Financial results

Key highlights

  • Board approved unaudited standalone and consolidated results for the quarter and half year ended 30th September, 2026, with Limited Review Reports.
  • Board approved sale of 90% of its stake in wholly owned subsidiary Mangalam Nutrifeeds Private Limited to Anil Danga and Sureshkumar Sharma; holding falls from 100% to 10%.
  • Board approved sale of its entire 25% stake in associate Sharayu Mangalam Bioseeds Private Limited to Ramchandra Gajanan Nake. Consideration is not stated and definitive agreements are yet to be signed.

Why it's rated notable: the year-on-year change is 39% (20% or more for adverse news)

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Results- Financial Results For Quarter Ended 30Th September 2026

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Other financial results filings this fortnight

All financial results filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.